Report Detail

TABLE OF CONTENTS

    1. Introduction

    • 1.1 Scope of the Study
    • 1.2 The Insight Partners Research Report Guidance

    2. Asia Pacific Smart Inhalers Market - Key Takeaways

      3. Asia Pacific Smart Inhalers Market - Market Landscape

      • 3.1 Overview
      • 3.2 Market Segmentation
        • 3.2.1 Asia Pacific Smart Inhalers Market - By Product
        • 3.2.2 Asia Pacific Smart Inhalers Market - By Disorder
        • 3.2.3 Asia Pacific Smart Inhalers Market - By End User
        • 3.2.4 Asia Pacific Smart Inhalers Market - By Asia Pacific Region
      • 3.3 PEST Analysis

      4. Asia Pacific Smart Inhalers Market - Key Market Dynamics

      • 4.1 Key Market Drivers
        • 4.1.1 Increasing Levels of Air Pollution as well as Rise in the Smoking Habits
        • 4.1.2 Rising Prevalence of Asthma and COPD Across the Asia Pacific
        • 4.1.3 Growing Geriatric Population
      • 4.2 Key Market Restraints
        • 4.2.1 Risks Associated with Cyber Threats
        • 4.2.2 Limited Knowledge Regarding the Use of Smart Inhalers
      • 4.3 Key Market Opportunity
        • 4.3.1 Growth in the Global Healthcare Market
      • 4.4 Future Trend
        • 4.4.1 Increasing Acceptance of Mobile Health Technology
      • 4.5 Impact Analysis

      5. Smart Inhalers Market - Asia Pacific Analysis

      • 5.1 Asia Pacific Smart Inhalers Market Revenue Forecasts And Analysis
      • 5.2 Performance Of Key Players

      6. Smart Inhalers Market Analysis And Forecasts To 2027 - Product

      • 6.1 Overview
      • 6.2 Asia Pacific Smart Inhalers Market Share By PRODUCT 2018 & 2027 (%)
      • 6.3 Inhalers Market
        • 6.3.1 Overview
        • 6.3.2 Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
      • 6.4 Nebulizers Market
        • 6.4.1 Overview
        • 6.4.2 Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)

      7. Smart Inhalers Market Analysis And Forecasts To 2027 - Disorder

      • 7.1 Overview
      • 7.2 Asia Pacific Smart Inhalers Market Share By Application 2018 & 2027 (%)
      • 7.3 Asthma Diabetes
        • 7.3.1 Overview
        • 7.3.2 Asthma Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4 Chronic Obstructive Pulmonary Disease Market
        • 7.4.1 Overview
        • 7.4.2 Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2027 (US$ Mn)

      8. Smart Inhalers Market Analysis And Forecasts To 2027 -End User

      • 8.1 Overview
      • 8.2 Asia Pacific Smart Inhalers Market Share By End User 2018 & 2027 (%)
      • 8.3 Hospitals & Clinics Market
        • 8.3.1 Overview
        • 8.3.2 Hospitals & Clinics Market Revenue and Forecast to 2027 (US$ Mn)
      • 8.4 Home Care Settings Market
        • 8.4.1 Overview
        • 8.4.2 Home-Care Settings Market Revenue and Forecast to 2027 (US$ Mn)

      9. Smart Inhalers Market Revenue And Forecasts To 2027 - Asia Pacific Analysis

      • 9.1 Asia Pacific Smart inhalers Market Revenue and Forecasts to 2027
        • 9.1.1 Asia Pacific Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
        • 9.1.2 Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)
        • 9.1.3 Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)
        • 9.1.4 Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)
        • 9.1.5 Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By Country (%)
        • 9.1.6 Japan Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
          • 9.1.6.1 Japan Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
          • 9.1.6.2 Japan Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)
          • 9.1.6.3 Japan Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)
          • 9.1.6.4 Japan Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)
        • 9.1.7 China Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
          • 9.1.7.1 China Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
          • 9.1.7.2 China Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)
          • 9.1.7.3 China Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)
          • 9.1.7.4 China Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)
        • 9.1.8 India Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
          • 9.1.8.1 India Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
          • 9.1.8.2 India Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)
          • 9.1.8.3 India Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)
          • 9.1.8.4 India Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)
        • 9.1.9 South Korea Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
          • 9.1.9.1 South Korea Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
          • 9.1.9.2 South Korea Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)
          • 9.1.9.3 South Korea Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)
          • 9.1.9.4 South Korea Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)
        • 9.1.10 Australia Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
          • 9.1.10.1 Australia Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
          • 9.1.10.2 Australia Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)
          • 9.1.10.3 Australia Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)
          • 9.1.10.4 Australia Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

        10. Smart Inhalers Market- Industry Landscape

        • 10.1 Overview
        • 10.2 Comparative Company Analysis
        • 10.3 Growth Strategies Done By The Companies In The Market, (%)
        • 10.4 Organic Developments
          • 10.4.1 Overview
        • 10.5 Inorganic Developments
          • 10.5.1 Overview

        11. Smart Inhalers Market-Key Company Profiles

        • 11.1 Glaxosmithkline Plc.
          • 11.1.1 Key Facts
          • 11.1.2 Business Description
          • 11.1.3 Financial Overview
          • 11.1.4 Product Portfolio
          • 11.1.5 SWOT Analysis
          • 11.1.6 Key Developments
        • 11.2 Adherium Limited
          • 11.2.1 Key Facts
          • 11.2.2 Business Description
          • 11.2.3 Financial Overview
          • 11.2.4 Product Portfolio
          • 11.2.5 SWOT Analysis
          • 11.2.6 Key Developments
        • 11.3 Novartis AG
          • 11.3.1 Key Facts
          • 11.3.2 Business Description
          • 11.3.3 Financial Overview
          • 11.3.4 Product Portfolio
          • 11.3.5 SWOT Analysis
          • 11.3.6 Key Developments
        • 11.4 Vectura Group Plc
          • 11.4.1 Key Facts
          • 11.4.2 Business Description
          • 11.4.3 Financial Overview
          • 11.4.4 Product Portfolio
          • 11.4.5 SWOT Analysis
          • 11.4.6 Key Developments
        • 11.5 Cohero Health, Inc.
          • 11.5.1 Key Facts
          • 11.5.2 Business Description
          • 11.5.3 Financial Overview
          • 11.5.4 Product Portfolio
          • 11.5.5 SWOT Analysis
          • 11.5.6 Key Developments
        • 11.6 Crux Product Design Ltd
          • 11.6.1 Key Facts
          • 11.6.2 Business Description
          • 11.6.3 Financial Information
          • 11.6.4 Product Portfolio
          • 11.6.5 SWOT Analysis
          • 11.6.6 Key Developments
        • 11.7 Findair Sp. Z O. O.
          • 11.7.1 Key Facts
          • 11.7.2 Business Description
          • 11.7.3 Financial Overview
          • 11.7.4 Product Portfolio
          • 11.7.5 SWOT Analysis
          • 11.7.6 Key Developments
        • 11.8 Teva Pharmaceutical Industries Ltd.
          • 11.8.1 Key Facts
          • 11.8.2 Business Description
          • 11.8.3 Financial Overview
          • 11.8.4 Product Portfolio
          • 11.8.5 SWOT Analysis
          • 11.8.6 Key Developments
        • 11.9 3M
          • 11.9.1 Key Facts
          • 11.9.2 Business Description
          • 11.9.3 Financial Overview
          • 11.9.4 Product Portfolio
          • 11.9.5 SWOT Analysis
          • 11.9.6 Key Developments
        • 11.10 Amiko Digital Health Limited
          • 11.10.1 Key Facts
          • 11.10.2 Business Description
          • 11.10.3 Financial Overview
          • 11.10.4 Product Portfolio
          • 11.10.5 SWOT Analysis
          • 11.10.6 Key Developments

        12. Appendix

        • 12.1 About The Insight Partners

      The Asia Pacific smart inhalers market is expected to reach US$ 1,539.97 Mn in 2027 from US$ 186.63 Mn in 2018. The market is estimated to grow with a CAGR of 27.2% from 2019-2027.
      The growth of the smart inhalers market is primarily attributed to the growing geriatric population rising prevalence of COPD and asthma, along with rising awareness regarding the medical condition as well as the presence of supportive associations in the region. However, risks associated with cyber threats with smart inhalers are likely to pose a negative impact on market growth. On the other hand, the development of growth in the Asia pacific healthcare market is likely to have a positive impact on the growth of the Europe smart inhalers market in the coming years.
      With rapid urbanization there has been growth in various adverse factors that have led to the growth of respiratory diseases across the Asia Pacific. Some of the factors leading to growth in the number of asthma and COPD cases across the Asia Pacific are a rise in air pollution levels and increasing smoking habits.
      The rise in air pollution levels has been a matter of rising concern in developed as well as developing economies. As per data published by the World Health Organization (WHO) released during May 2018, 9 out of 10 individuals are believed to breathe air containing high levels of pollutants. Data published by WHO reveals that approximately 7 million people die every year due to exposure to fine particles present in polluted air, which penetrate deep into the lungs and the cardiovascular system. This leads to various diseases such as lung cancer, pneumonia, chronic obstructive pulmonary diseases and respiratory infections, among others. In 2016 Among the 2.2 million air pollution-related deaths in Asia pacific region, 29% were due to heart disease, 27% stroke, 22% chronic obstructive pulmonary disease, 14% lung cancer and 8% pneumonia. Additionally increasing indirect effects of air pollution like growing climate change, because of transport is the fastest growing source of fossil-fuel emissions of carbon dioxide (CO2) which is a most significant contributor of climate change. In 2017 World Health Organization (WHO) held a member states consultation on addressing the health impact of air pollution in the western pacific region, and continues to take steps to improve the situation. Children living near roads with heavy-duty vehicle traffic have twice the risk of respiratory problems as those living near less congested streets. Hence, the rising levels of air pollution coupled are anticipated to drive the demand for the smart inhalers market during the forecast period.
      In 2018, the inhalers segment held a largest market share of the smart inhalers market, by product. The inhalers is expected to dominate its market share in 2027 owing to the increasing mortality rate of asthma. The inhalers segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.
      Home-care setting segment a largest market share of the smart inhalers market, by end user in 2018. This segment is also expected to dominate the market in 2027. As smart inhaler devices are connected digitally, enabling the patients to get advice from their physicians, even when situated far away. Home-care setting segment is also expected to grow at the fastest growth rate during the forecast period, 2019 to 2027.
      Some of the major primary and secondary sources for smart inhalers included in the report are, GlaxoSmithKline plc, Adherium Ltd., Vectura Group plc, Novartis AG, Findair Sp. z o. o., Cohero Health, Crux Product Design Ltd, Teva Pharmaceuticals, 3M, Amiko Digital Health Limited, and others.


      Summary:
      Get latest Market Research Reports on Asia Pacific Smart Inhalers. Industry analysis & Market Report on Asia Pacific Smart Inhalers is a syndicated market report, published as Asia Pacific Smart Inhalers Market to 2027 - Regional Analysis and Forecasts by Product (Nebulizers and Inhalers); Disorder (Chronic Obstructive Pulmonary Disease (COPD), and Asthma); End User (Home-Care Settings and Hospitals & Clinics), and Country. It is complete Research Study and Industry Analysis of Asia Pacific Smart Inhalers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,000.00
      $4,000.00
      $5,000.00
      2,339.02
      3,118.69
      3,898.37
      2,719.88
      3,626.51
      4,533.14
      327,369.00
      436,492.00
      545,615.00
      214,149.90
      285,533.20
      356,916.50
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report